Medical imaging is a key asset in the drug development process as it can provide efficacy evaluation and safety monitoring data needed in clinical trials for regulatory submission in addition imaging provides insights on the drug mechanism of action moa and drug effects that can help researchers take scientifically sounded decisions. The book is organized in three parts covering an overview on imaging and trial management within seven chapters therapeutic areas where imaging is employed in clinical trials within eight chapters and the future of imaging in clinical trials in a closing chapter eighteen authors supported the three editors. Medical imaging in clinical trials is a key text in understanding the methodology and the metrics that are required in the field of medical imaging as the pharmaceutical biotech and medical device industries continue to identify ways to improve and speed up product development medical imaging plays a more significant role. In the last few years the use of medical imaging has increased exponentially in routine clinical practice this has been reflected in a rapidly increasing use of medical imaging in clinical trials through all phases more recently this has culminated in a number of inter disciplinary meetings with the various stake holders including the fda